Page last updated: 2024-11-05

tranexamic acid and Purpura, Thrombotic Thrombocytopenic

tranexamic acid has been researched along with Purpura, Thrombotic Thrombocytopenic in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Purpura, Thrombotic Thrombocytopenic: An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tuccori, M1
Guidi, B1
Carulli, G1
Blandizzi, C1
Del Tacca, M1
Di Paolo, M1

Other Studies

1 other study available for tranexamic acid and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Severe thrombocytopenia and haemolytic anaemia associated with ciprofloxacin: a case report with fatal outcome.
    Platelets, 2008, Volume: 19, Issue:5

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Ciprofloxacin; Diagnostic Errors; Fatal

2008